Terminated NA INTERVENTIONAL 2-arm NCT04487691

Nebulized PL for Post-COVID-19 Syndrome

Autologous Nebulized Platelet Lysate for Post COVID-19 Syndrome

Sponsor: Regenexx, LLC

Conditions Covid19

Interventions Nebulized Platelet Lysate Nebulized Sterile Saline

Updated 7 times since 2020 Last updated: Jan 25, 2022 Started: Dec 8, 2020 Primary completion: Jun 15, 2021 Completion: Jun 15, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Low enrollment

Other terminated trials from Regenexx, LLC

More terminations from Regenexx, LLC

Other Covid19 trials with similar outcome

Browse all Covid19 trials

This NA trial investigates Covid19 and is currently terminated or withdrawn. Regenexx, LLC leads this study, which shows 7 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Mar 2022 — Jul 2024 [monthly]

Terminated NA

Status: Active Not Recruiting → Terminated
Apr 2021 — Mar 2022 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Jan 2021 — Apr 2021 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 2 earlier versions

Sep 2020 — Jan 2021 [monthly]

Not Yet Recruiting NA
Aug 2020 — Sep 2020 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Regenexx, LLC

Data source: Regenexx, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Broomfield, United States